News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) Announces Conference Call To Discuss Second Quarter 2014 Financial Results


7/30/2014 9:19:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Menlo Park, Calif., July 30, 2014 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the second quarter ended June 30, 2014, on Monday, August 11, 2014, after the market close. Geron's management will also host a conference call for analysts and investors on Monday August 11, 2014, at 4:30 p.m. Eastern Time to discuss the company's second quarter results and recent events.

Participants can access the conference call live via telephone by dialing 866-277-1184 (U.S.); 617-597-5360 (international). The passcode is 52570360. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/f44w6tg8/lan/en . The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through September 12, 2014.

About Geron

Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES